177 related articles for article (PubMed ID: 37415153)
1. Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to Notch1 inhibitors via epigenetic reprogramming.
Gu X; Min W; Zeng Y; Fan N; Qian Q
J Transl Med; 2023 Jul; 21(1):443. PubMed ID: 37415153
[TBL] [Abstract][Full Text] [Related]
2. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
3. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
4. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
5. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway.
Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C
Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880
[TBL] [Abstract][Full Text] [Related]
6. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity.
Gao B; Xu W; Zhong L; Zhang Q; Su Y; Xiong S
Eur J Immunol; 2013 Aug; 43(8):2174-84. PubMed ID: 23670564
[TBL] [Abstract][Full Text] [Related]
7. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
8. CircROR1 upregulates CCNE1 expression to promote melanoma invasion and metastasis by recruiting KAT2A.
Sun L; Bin S; Huang C; Wang Q
Exp Dermatol; 2024 Apr; 33(4):e15071. PubMed ID: 38566477
[TBL] [Abstract][Full Text] [Related]
9. FOXC1‑mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast‑like synoviocytes in rheumatoid arthritis via NF‑κB signaling pathway.
Wei Y; Huang X; Ma Y; Dai L
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35946462
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Tripartite motif-containing 22 (TRIM22)relieved the apoptosis of lens epithelial cells by suppressing the expression of TNF receptor-associated factor 6 (TRAF6).
Meng K; Fang C
Bioengineered; 2021 Dec; 12(1):7213-7222. PubMed ID: 34558381
[TBL] [Abstract][Full Text] [Related]
11. Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
Yan W; Shi X; Wang H; Liao A; Yang W
J Transl Med; 2022 Jun; 20(1):296. PubMed ID: 35773729
[TBL] [Abstract][Full Text] [Related]
12. Identification of TRIM22 as a RING finger E3 ubiquitin ligase.
Duan Z; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2008 Sep; 374(3):502-6. PubMed ID: 18656448
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TRIM22 Relieves Oxygen-Glucose Deprivation/Reoxygenation-Induced Apoptosis and Inflammation Through Inhibition of NF-κB/NLRP3 Axis.
Kang C; Lu Z; Zhu G; Chen Y; Wu Y
Cell Mol Neurobiol; 2021 Mar; 41(2):341-351. PubMed ID: 32335773
[TBL] [Abstract][Full Text] [Related]
14. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
[TBL] [Abstract][Full Text] [Related]
15. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
16. Role of TRIM22 in ulcerative colitis and its underlying mechanisms.
Ye B; Lu Z
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35674157
[TBL] [Abstract][Full Text] [Related]
17. Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
Aseem SO; Jalan-Sakrikar N; Chi C; Navarro-Corcuera A; De Assuncao TM; Hamdan FH; Chowdhury S; Banales JM; Johnsen SA; Shah VH; Huebert RC
Gastroenterology; 2021 Feb; 160(3):889-905.e10. PubMed ID: 33058867
[TBL] [Abstract][Full Text] [Related]
18. TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity κB/beclin 1 pathway.
Lou J; Wang Y; Zheng X; Qiu W
J Cell Biochem; 2018 Nov; 119(11):8971-8980. PubMed ID: 30011088
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
20. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
